Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
1.25
HKD
|
+5.04%
|
|
+20.19%
|
-35.57%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,046
|
727.5
|
267.3
|
Enterprise Value (EV)
1 |
690.3
|
530
|
185.7
|
P/E ratio
|
-0.81
x
|
-5.28
x
|
-1.91
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
74.1
x
|
169
x
|
6.57
x
|
EV / Revenue
|
48.9
x
|
123
x
|
4.57
x
|
EV / EBITDA
|
-8.25
x
|
-3.83
x
|
-1.59
x
|
EV / FCF
|
-129,749,953
x
|
-6,080,007
x
|
-1,862,497
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
Price to Book
|
2.75
x
|
3.24
x
|
2.84
x
|
Nbr of stocks (in thousands)
|
767,891
|
731,767
|
742,794
|
Reference price
2 |
1.362
|
0.9941
|
0.3598
|
Announcement Date
|
4/19/21
|
4/28/22
|
4/27/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1.483
|
5.419
|
14.11
|
4.308
|
40.66
|
EBITDA
1 |
-36.24
|
-52.21
|
-83.63
|
-138.4
|
-117.1
|
EBIT
1 |
-37.29
|
-55.42
|
-87.88
|
-143
|
-121.9
|
Operating Margin
|
-2,514.5%
|
-1,022.66%
|
-622.95%
|
-3,319.38%
|
-299.78%
|
Earnings before Tax (EBT)
1 |
-34.64
|
-67.59
|
-296.6
|
-137.8
|
-137
|
Net income
1 |
-34.58
|
-67.46
|
-296.4
|
-137.8
|
-137.2
|
Net margin
|
-2,331.96%
|
-1,244.88%
|
-2,101.06%
|
-3,198.17%
|
-337.49%
|
EPS
2 |
-0.3127
|
-0.5719
|
-1.686
|
-0.1881
|
-0.1881
|
Free Cash Flow
|
-
|
-40.35
|
-5.32
|
-87.17
|
-99.7
|
FCF margin
|
-
|
-744.6%
|
-37.71%
|
-2,023.34%
|
-245.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/30/20
|
11/30/20
|
4/19/21
|
4/28/22
|
4/27/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
97.9
|
170
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
356
|
198
|
81.6
|
Leverage (Debt/EBITDA)
|
-2.7
x
|
-3.256
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-40.4
|
-5.32
|
-87.2
|
-99.7
|
ROE (net income / shareholders' equity)
|
-
|
56.4%
|
-286%
|
-47.2%
|
-87%
|
ROA (Net income/ Total Assets)
|
-
|
-45.3%
|
-24%
|
-26.6%
|
-29.6%
|
Assets
1 |
-
|
149
|
1,236
|
517.3
|
463.4
|
Book Value Per Share
2 |
-0.7800
|
-1.260
|
0.4900
|
0.3100
|
0.1300
|
Cash Flow per Share
2 |
0.5500
|
0.2700
|
0.4900
|
0.3000
|
0.2300
|
Capex
1 |
4.87
|
12.9
|
0.47
|
13.5
|
17.9
|
Capex / Sales
|
328.25%
|
238.9%
|
3.32%
|
312.23%
|
44.06%
|
Announcement Date
|
11/30/20
|
11/30/20
|
4/19/21
|
4/28/22
|
4/27/23
|
|
1st Jan change
|
Capi.
|
---|
| -35.57% | 117M | | -4.66% | 86.13B | | +1.32% | 39.82B | | -19.27% | 30.42B | | +57.86% | 25.23B | | -16.09% | 15.36B | | -9.14% | 11.95B | | -17.69% | 11.6B | | -43.00% | 11.51B | | +5.24% | 8.71B |
Biopharmaceuticals
|